| pubmed-article:19345578 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C0019225 | lld:lifeskim |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C0279516 | lld:lifeskim |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C0887953 | lld:lifeskim |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:19345578 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:19345578 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:19345578 | pubmed:dateCreated | 2009-4-17 | lld:pubmed |
| pubmed-article:19345578 | pubmed:abstractText | The synthesis of a new series of oxazolidinones having spiro[2,4]heptane moieties is described. Their in vitro antibacterial activities against both Gram-positive and Gram-negative bacteria were tested and the effect of substituents on the oxazolidinone ring was investigated. A particular compound Ih having fluoro group showed the most potent antibacterial activity. | lld:pubmed |
| pubmed-article:19345578 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19345578 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19345578 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19345578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19345578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19345578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19345578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19345578 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19345578 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19345578 | pubmed:month | May | lld:pubmed |
| pubmed-article:19345578 | pubmed:issn | 1464-3405 | lld:pubmed |
| pubmed-article:19345578 | pubmed:author | pubmed-author:KimSo-YoungSY | lld:pubmed |
| pubmed-article:19345578 | pubmed:author | pubmed-author:OhChang-HyunC... | lld:pubmed |
| pubmed-article:19345578 | pubmed:author | pubmed-author:ChoJung-Hyuck... | lld:pubmed |
| pubmed-article:19345578 | pubmed:author | pubmed-author:YooKyung HoKH | lld:pubmed |
| pubmed-article:19345578 | pubmed:author | pubmed-author:ParkHyeong... | lld:pubmed |
| pubmed-article:19345578 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19345578 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19345578 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:19345578 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19345578 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19345578 | pubmed:pagination | 2558-61 | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:meshHeading | pubmed-meshheading:19345578... | lld:pubmed |
| pubmed-article:19345578 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19345578 | pubmed:articleTitle | Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties. | lld:pubmed |
| pubmed-article:19345578 | pubmed:affiliation | Life Sciences Research Division, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 130-650, Republic of Korea. | lld:pubmed |
| pubmed-article:19345578 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19345578 | lld:chembl |
